MCKESSON CORPORATION 2024-02-28 Health serious FDA
Health · FDA · Recall #FDA-D-0347-2024
CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel… Recall
Issued February 28, 2024 · MCKESSON CORPORATION
In February 2024, MCKESSON CORPORATION recalled the CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
What you should do
- 1 Stop using CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact MCKESSON CORPORATION to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- MCKESSON CORPORATION
- Category
- Health
- Recall date
- February 28, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the US
- Recall number
- FDA-D-0347-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- MCKESSON CORPORATION has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.